13
C NMR (101MHz, DMSO-d6) δ 173.12 (C11); 157.42 (d, J = 25.8 Hz, C4); 149.98 (C2); 139.56 (d, J = 228.8 Hz, C5); 130.06 (d, J = 33.1 Hz, C6); 51.26 (C14); 47.22 (C7); 32.72 (C10); 27.61 (C8), 21.15 (C9) HRMS (+ESI): m/z calculated for C10H14FN2O4 [M + H] + 245.0938, found 245.0932 (-2.4ppm), (-ESI): m/z calculated for C10H12FN2O4 [M -H] -243.0781, found 243.0785 (1.6 ppm). 5FU3 ester 1 H NMR (400MHz, DMSO-d6) δ 7.82 (d, J = 5.5 Hz, 1H, H6); 3.76 (t, J = 6.6 Hz, 2H, H7); 3.57 (s, 3H, H14); 2.33 (t, J = 6.9 Hz, 2H, H10); 1.59 -1.42 (m, 4H, H8 H9) 13 
5-(5-fluoro-2,4-dioxo-1H,3H-pyrimidin-6-yl)pentanoic acid (5FU6

S2.2 Buffers.
Unless otherwise indicated, phosphate buffer saline (PBS) is 0.01 M phosphate buffer in a 0.8% saline solution, pH 7.5. Coating buffer is a 0.05 M carbonate-bicarbonate buffer, pH 9.6. PBST is PBS with 0.05% Tween 20, pH 7.5. Citrate buffer is 0.04 M sodium citrate, pH 5.5. The substrate solution contains 0.01% 3,3',5,5'-tetramethylbenzidine (TMB) and 0.004% H2O2 in citrate buffer. Borate buffer is 0.2 M boric acid/sodium borate, pH 8.7. 
S2.3 Hapten densities of the bioconjugates
S2.4 Competitive assays using As337 and different bioconjugates of the hapten 5FU6
S2.5 ELISA optimization
Standard calibration curves were carried out at different conditions, varying only one parameter individually. The pH values were studied from 5.5 to 10.5, the conductivity changed from 0 to 50 mS cm -1 , the tween 20 concentration was selected between 0 and 0.5%, calcium concentration was optimized from 0 to 8 mM, competition time was tested between 10 and 60 min and incubation time from 0 to 12 h. The value that reported a highest ratio Amax-min/IC50 was selected for following assays. Figure S3 . Structures of related tegafur compounds used in the cross-reactivity studies. Abbreviations: 5BrUrd = 5-bromo-2'-deoxyuridine; 5FUrd = 5-fluoro-2'-deoxyuridine; 5FDMU = 5-Fluoro-1,3-dimethyluracil; 5BrU = 5-Bromouracil; 5FU = 5-Fluorouracil. 
S2.6 Specificity studies
S2.7 Matrix effect studies
